Browsing Category
Chemical Industry News
328 posts
AdvanSix (NYSE: ASIX) FY2025 results show earnings resilience despite flat revenue and cyclical end-market pressure
AdvanSix Inc.’s FY2025 results reveal why earnings held up despite flat revenue and weak chemical markets. Find out what this signals for 2026.
Univar Solutions expands glycolic acid distribution in EMEA through exclusive CABB Group partnership
Find out how Univar Solutions’ exclusive glycolic acid partnership with CABB Group could accelerate innovation across beauty, home care, and industrial cleaning in EMEA.
Amines & Plasticizers (NSE: AMNPLST) Q3 & 9MFY26 results highlight operational recovery amid raw material volatility and cautious demand outlook
Amines & Plasticizers Limited’s Q3FY26 results reveal how supply disruptions, product mix, and margins shape recovery prospects. Read the full analysis.
Galaxy Surfactants (NSE: GALAXYSURF) Q3 FY26 results signal portfolio resilience as specialty growth offsets global surfactant pressures
Galaxy Surfactants Limited Q3 FY26 results reveal how specialty care growth is offsetting global surfactant pressure. Find out what this means for investors.
Is FMC Corporation (NYSE: FMC) for sale? What the 2026 strategic review means for its future
FMC Corporation explores a full sale as part of its 2026 strategic review, signaling major shifts in agri-chemical strategy. See what it means for investors and the sector.
Arclin completes acquisition of Willamette Valley, expands materials science platform
Arclin has acquired The Willamette Valley Company to expand its materials science platform. Find out how this move reshapes the specialty chemicals landscape.
Why LyondellBasell’s $1.5bn EBITDA plan could reshape how the petrochemicals sector defines profitability
LyondellBasell targets $1.5B in recurring EBITDA by 2028 as it pivots toward capital discipline, cost efficiency, and structural margin recovery. Read the full analysis.
Why is Dow (NYSE: DOW) laying off 4,500 employees—and can it turn things around?
Dow targets $2B EBITDA uplift with new transformation plan after $1.5B Q4 loss. Find out what this means for investors, jobs, and the chemicals industry.
KKR and Novo Holdings double down on Sylvan to scale fungal biotechnology across Asia
KKR and Novo Holdings reinvest in Sylvan to scale fungal biotech in Asia. Find out what this means for industrial bio-platforms and global investors.
Is Bayer’s Roundup litigation strategy finally gaining legal traction with U.S. Supreme Court review?
Bayer's Roundup strategy just got a Supreme Court boost. Find out what the Durnell review could mean for tort law, federal preemption, and investor sentiment.